These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with no track record or liquidity, and...
Here are five biotech stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, these are not penny...
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Here are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. They are not penny stocks with absolutely no track record or...
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, AGCO, Alibaba, Baidu, Honeywell, L3Harris Technologies, Mosaic, Peloton Interactive and Teradyne.
Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant...
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Infinity Pharmaceuticals saw its shares almost double early on Thursday after the company announced good news.
The top analyst upgrades, downgrades and other research calls from Monday include BlackBerry, BP, Camping World, Deere, GrubHub, KLA-Tencor, Teva Pharmaceutical and Zions Bancorp.
The Russell U.S. Indexes undergo their annual rebalance after the United States markets close on Friday, June 23. Companies newly added to the indexes will see increased demand for the shares due to...
As the markets continue to stumble through May, and the volatility appears to be creeping up some, the end of the first-quarter earnings parade has opened the door for insiders to buy shares.
While the insider buying wasn’t as prolific as what we saw when the market was getting pummeled in January and February, it remains consistent.
Although stocks are beginning to make a comeback at this time, there are still those that are caught in the downturn slowing this recovery and punishing their shareholders.
Intrepid Potash reported disappointing fourth-quarter financial results before the markets opened on Monday morning.